Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV003891975 | SCV000315231 | benign | SLC52A3-related condition | 2021-05-06 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Invitae | RCV000554051 | SCV000657537 | benign | Brown-Vialetto-van Laere syndrome 1 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000246921 | SCV000713605 | benign | not specified | 2017-08-23 | criteria provided, single submitter | clinical testing | p.Phe3Phe in exon 2 of SLC52A3: This variant is not expected to have clinical si gnificance because it does not alter an amino acid residue, is not located withi n the splice consensus sequence, and has been identified in 0.94% (566/60078) of European chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.bro adinstitute.org; dbSNP rs139486822). |
Gene |
RCV001660355 | SCV001873482 | benign | not provided | 2020-09-02 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002379089 | SCV002691495 | likely benign | Inborn genetic diseases | 2019-07-11 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV002500930 | SCV002804327 | likely benign | Brown-Vialetto-van Laere syndrome 1; Progressive bulbar palsy of childhood | 2021-07-19 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001660355 | SCV004149749 | benign | not provided | 2023-12-01 | criteria provided, single submitter | clinical testing | SLC52A3: BP4, BP7, BS1, BS2 |
ARUP Laboratories, |
RCV001660355 | SCV004563866 | benign | not provided | 2023-10-10 | criteria provided, single submitter | clinical testing |